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ABSTRACT: 
In eukaryotes, cell proliferation is mediated through the cell cycle which consists of the G1 phase, 
S phase, G2 phase, and M phase. Conservation of the transcriptional pathways during the 
transition from G1 to S phase is essential for genomic stability and the alteration of the G1/S  
transcriptional pathway is linked to cancers. In budding yeast, the expressions of G1/S genes, 
which are crucial for early cell-cycle functions such as DNA replication and DNA repair, are 
coordinately regulated by MBF and SBF transcription factors. Transcriptional co-repressor Nrm1 
binds to G1-specific promoters via MBF, repressing the MBF-dependent genes which are 
expressed in late G1 and early S phase of the cell cycle. Nrm1 regulates the cellular response to 
replication stress in a Rad53 dependent manner. Rad53, which is a checkpoint effector protein 
kinase,  directly phosphorylates Nrm1, which restrains its binding with MBF-regulated promoters 
and thus mediates the expression of MBF-dependent genes countering to DNA replication stress. 
A histone-modifying enzyme, Set1 histone methyltransferase, facilitates Histone-3 Lysine-4 
(H3K4) methylation in yeast and H3K4 methylation is found to have a significant role in 
maintaining chromatin structure and also gene activation, silencing, splicing, and DNA repair. 
Set1 is also known to interact with non-histone substrates. Preliminary data have suggested that 
Set1 does interact with Nrm1 in vitro. The aim of this study was to determine the functional 
significance of the Set1-Nrm1 interaction. The results obtained suggest that Set1 regulates Nrm1 
protein stability. My data also suggests that interaction between Nrm1 and Set1 changes in the 
presence of replication stress. The interplay between the chromatin structure regulation and the 
DNA replication checkpoints can be useful for better insights into human diseases like cancer. 
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CHAPTER I: INTRODUCTION 
 
1.1 General Background: 
Chromosomes are the repository of the genetic information in prokaryotic as well as eukaryotic 
cells. Chromosomes are highly organized structures formed during cell division. However, in non-
dividing cells, the chromosomal material, chromatin, is dispersed in certain parts of the nucleus 
in a random manner (Dixon et al., 2016).  The organization of the DNA in chromatin controls the 
gene expression levels and also the maintenance of the genetic information in a dynamic way 
(Turner and O'Neill, 1995). Eukaryotic chromatin consists of fiber which contains DNA packaged 
by a special type of proteins called histones. Besides histone proteins, there are various other 
proteins found in chromatin that have important roles in gene expression and maintaining 
chromatin structure. The basic structural unit of chromatin is called nucleosome which comprises 
of 147 base pairs of DNA wound around the histone octamer (Campos and Reinberg, 2009). There 
are  5 different histones among which H2A, H2B, H3, H4 are called core histones and form histone 
octamer and H1 is called linker histone (Shilatifard, 2012). 
Histones are frequently subjected to post-translational modifications. Some of these 
modifications include acetylation, methylation, phosphorylation, ubiquitylation, ribosylation, 
etc. (Peterson and Laniel, 2004). Modification of histones can alter the structure and function of 
chromatin. Various chromatin-dependent functions such as replication, DNA-repair, and 
transcription are found to be regulated by histone modifications (Karlić et al., 2010). Histone can 
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be methylated in lysine (K) and arginine (R) residues of histone proteins. Histone methylation is 
generally observed in lysine residues of histone tails H3 and H4 (Kouzarides, 2002). Histone 
methylation was initially thought to be an irreversible process accompanied by histone 
methyltransferases but later on, with the discovery of demethylases, it became clear that histone 
methylation is indeed a reversible and dynamic process (Shi et al., 2004). 
The methyltransferase activity of histone methyltransferases is directed towards a specific lysine 
residue of histone 3 by a catalytic domain, SET domain, which is highly conserved across the 
species (Kouzarides, 2002). For methylation of histone 3 lysine 4 (H3K4) in yeast, Set1 histone 
methyltransferase (which belongs to SET-domain protein methyltransferase family) plays a 
crucial role. Set1 histone methyltransferase is found to possess a significant role in transcriptional 
activation and elongation (Dillon et al., 2005). The Set1 enzyme was first identified in a 
multiprotein complex named COMPASS. In Saccharomyces cerevisiae, COMPASS includes a 
catalytic subunit Set1 with seven other proteins(Malik and Bhaumik, 2010). Only one H3K4 
methyltransferase is present in yeast whereas in humans at least 10 H3K4 methyltransferases 
are found to be present. Out of which six of them (MLL1, MLL2, MLL3, MLL4, SET1A, and SET1B) 
consist of the SET domain belong to the family of mixed lineage leukemia (MLL) (Ansari et al., 
2009). Mixed lineage leukemia (MLL) family in humans shows homology to yeast Set1.  
DNA replication and DNA damage checkpoints are necessary for the effective response to 
replication stress, which is crucial for the survival of the cell and maintenance of genome stability 
(Jossen and Bermejo, 2013). During the cell cycle of Saccharomyces cerevisiae, G1-S transcription 
is regulated by the transcription factor complex called MBF (de Bruin and Wittenberg, 2009). MBF 
acts as a repressor of transcription outside of the G1 phase. Nrm1 is a protein that acts as a co‐
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repressor of MBF as cells exit the G1 phase. Nrm1 was recognized to be a part of the MBF 
complex, repressing the MBF-dependent genes which are expressed in late G1 and early S phase 
(Ofir et al., 2012). 
My research is to study the interaction between Set1 histone methyltransferase and the co-
repressor Nrm1 in the regulation of replication stress in the budding yeast Saccharomyces 
cerevisiae.  
 
1.2 Chromatin and Histones: 
Eukaryotic chromosomes are composed of chromatin fibers and proteins. Chromatins are DNA-
protein complexes conserved during evolution which act as the repository of genetic information 
(Ben-Haïm et al., 2001). The long double helix structure of DNA only could fit the cell when they 
were supercoiled and compactly arranged. Thus, chromatin is a highly condensed structure that 
consumes less space and makes it more organized. During replication, chromatin further 
condenses to form chromosomes which help in the proper separation of the genetic material 
between daughter cells (Poirier and Marko, 2002). Chromatin consists of the fundamental 
repeating unit called nucleosomes which consist of octamers of core histones (two each of 
histones H2A, H2B, H3, and H4) encircled by approximately two turns of DNA (145 to 147 bp of 
DNA) (Benson et al., 2006, Tan and Davey, 2011). Two nucleosome cores are linked by a varying 
length of linker DNA associated with linker histone H1 (Bednar et al., 1998). Different linker 
histone variants have been identified which are specific to the species, tissues, or developmental 
stages.  11 mammalian H1 variants and the avian erythrocyte variant H5 have been identified so 
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far (Bednar et al., 2017). Linker histones play an important role in the assembly, compactness, 
and maintenance of the 30 nm chromatin fibers and the higher-order chromatin structures 
(Maresca et al., 2005, Robinson and Rhodes, 2006).  
 
1.3 Post-translational modifications of histone: 
Histones are subjected to various post-translational modifications. N-terminal portions of histone 
proteins protrude from the nucleosome, often referred to as histone tails. Histone tails are 
unstructured, and it’s believed that they contribute to the formation of the higher-order 
chromatin structures by moderating inter-nucleosomal interactions (Luger et al., 1997). Histones 
are covalently modified at various amino acid residues mostly located on the N-terminal tails of 
histones. The most common histone modifications are acetylation, phosphorylation, 
methylation, and ubiquitylation (Garcia et al., 2007, Nishioka et al., 2002). Besides these, there 
are few other modifications that includes sumoylation, ribosylation, and deamination. (Bannister 
and Kouzarides, 2011, Cuthbert et al., 2004, Nathan et al., 2003). 
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Fig. 1.1: Histone post-translational modifications sites (Figure adapted from the Thermo Fisher Scientific website)  
Important sites of histone post-translational modifications that affect epigenetics are shown in the figure. H2A, H2B, 
H3 and H4 are the core histones. H2A.X is a variant of histone H2A which forms 2–25% of histone H2A in mammals 
according to the organism and cell type (Dickey et al., 2009). 
 
1.3.1 Acetylation:  
Histone acetylation can be seen in all four core histones. Histone acetylation is specific to Lysine 
(K) residue. The acetylation and deacetylation of histone are facilitated by enzymes histone 
acetyltransferases and histone deacetylases respectively (Kurdistani and Grunstein, 2003). 
Chaperones help in the assembly of newly synthesized histone onto nucleosome (De Koning et 
al., 2007). Newly produced histones are rapidly acetylated by histone acetyltransferases which 
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facilitate the transfer of an acetyl group from acetyl coenzyme A to the ɛ-amino group of lysine 
residues (Shahbazian and Grunstein, 2007). As soon as after the deposition of histones onto the 
DNA, deacetylase enzymes deacetylate it. The acetylation pattern can be recognized later for 
reacetylation to support various functions (Tamburini and Tyler, 2005). Histone acetylation has 
several functions in chromatin condensation and stability, nucleosome assembly, and also in 
transcription (Shahbazian and Grunstein, 2007). 
 
1.3.2 Methylation: 
Histone methylation can occur on arginines(R), lysines(K), and histidines(H) residues. Lysines can 
be mono-, di-, or tri-methylated on their ɛ-amine group (Greer and Shi, 2012). Arginines can be 
mono-methylated or di-methylated on their guanidinyl group. On histidines, mono-methylation 
occurs which is indeed very rare and hasn’t been studied much. Depending on the degree of 
methylation and the location of the methylated residue, they can exert various functions (Klose 
and Zhang, 2007). Histone methylation is also a reversible process that involves site-specific 
methyltransferases and demethylases (Greer and Shi, 2012). 
 
1.3.3 Phosphorylation: 
Histone phosphorylation can occur on serine(S), threonine(T) and tyrosine(Y) residues (Rossetto 
et al., 2012). Phosphorylation is catalyzed by a group of protein kinases and dephosphorylation 
by phosphatases. Histone phosphorylation can involve in various nuclear processes such as DNA 
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damage repair, transcriptional regulation, and chromatin compaction during mitosis and meiosis 
and also in apoptosis-induced chromatin condensation (Ajiro, 2000, Clements et al., 2003, Downs 
et al., 2004, Dai et al., 2005, Sassone-Corsi et al., 1999). 
 
1.3.4 Ubiquitination: 
Ubiquitin is a small protein comprised of 76 amino acids. Ubiquitination involves three steps of 
separate enzymatic reactions in which ubiquitin is first activated by ubiquitin-activating enzyme, 
after which ubiquitin-conjugating enzyme catalyzes the ubiquitin conjugation via a thioester 
bond to a cysteine residue and finally ubiquitin is transferred to a target lysine(K) residue by the 
help of ligases (Weake and Workman, 2008). Histone H2A and H2B are found to be 
monoubiquitinated whereas H3 and H4 are found to be polyubiquitinated (Hwang et al., 2003, 
Wang et al., 2006). Histone ubiquitination is involved in several functions like modulation of gene 
expression, play a role in stem cell maintenance and differentiation, chromatin function, and so 
on (Ma et al., 2011, Park et al., 2003, Xiao et al., 2005). 
 
1.4 Set1 histone methyltransferase:  
 Histone lysine methylation plays a crucial role in gene expression, cell cycle, and stability of 
genome and chromatin structure (Black et al., 2012). Lysine residues can either be mono-, di-, or 
tri-methylated (Bannister and Kouzarides, 2003). Histone methylation is regulated by two types 
of enzymes which are histone methyltransferases and histone demethylases. Histone 
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methylation is a dynamic and enzymatically reversible process (Shi and Whetstine, 2007). A large 
number of studies have focused on the methylation of histone at lysine residues and the enzymes 
involved in this mechanism. Histones are found to be methylated at K4, K9, K27, K36 & K79 
residue at H3 tail and K20 residue at H4 tail (Malik and Bhaumik, 2010). H3K4 methylation is 
facilitated by the enzyme Set1 histone methyltransferase and H3K4 methylation is found to have 
a significant role in gene activation and silencing, splicing, and DNA repair (Shilatifard, 2008). Set1 
is enzymatically functional when it is assembled into the multi-subunit COMPASS complex. 
Various COMPASS subunits are required for the proper methylation of H3K4 (Schneider et al., 
2005). 
 
1.5 The compass family of histone H3K4 
methyltransferases 
SET-domain which is located at the C-terminus of Set1 is the evolutionarily conserved domain. 
Besides the SET domain, other associated subunits are also conserved from yeast to higher 
eukaryotes, human (van Nuland et al., 2013).  
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Fig. 1.2: The COMPASS family of histone H3 lysine 4 (H3K4) methyltransferases in yeast, flies, and humans 
(Figure adapted from Sze and Shilatifard (2016)) 
 
In yeast, Set1/COMPASS is composed of eight subunits which are Set1, Swd1 (Cps50); Swd2 
(Cps35); Swd3 (Cps30); Bre2 (Cps60); Sdc1 (Cps25); Spp1 (Cps40), and Shg1 (Dehé et al., 2006). 
Yeast only has one Set/COMPASS which facilitates all the H3K4 methylation patterns.  In 
Drosophila melanogaster, there are three H3K4 methyltransferases, named dSet1, trithorax (Trx), 
and trithorax-related (Trr) which show homology to the yeast Set1/COMPASS (Shilatifard, 2012). 
Similarly, in humans, Set1A, Set1B, MLL1, MLL2, MLL3, and MLL4 are present which are homologs 
of yeast Set1 (Shilatifard, 2012). Core subunits that are highly conserved across the species are 
P a g e  | 10 
 
highlighted in blue color in Fig. 1.2 whereas the subunits which are specific only to the particular 
complex are shown in green. 
 
1.6 Structure of Set1 histone methyltransferase: 
The Set1/COMPASS complex consists of eight subunits, out of which Set1 is the catalytic subunit 
and is a central component of the complex (Roguev et al., 2001). The protein subunits within the 
Set1 complex are found to interact with each other. A study by Dehé et al. (2006) found that 
different subunits have their own function to contribute to H3K4 methylation. They used a 
bacterial two-hybrid system. They concluded that there is the formation of Swd1-Swd3 
heterodimer. Set1, Swd1, and Swd3 are required for the whole complex integrity and play a major 
role in H3K4 methylation. Bre2 and Sdc1 also showed to form a heterodimer and need a SET 
domain for the interaction with the complex. Set1 amount highly reduced in the absence of the 
Swd1-Swd3 heterodimer, and also in the absence of Spp1. Bre2 and Sdc1 heteromer was found 
to be required for H3K4 di- and trimethylation but not required for Set1C integrity. Shg1 showed 
to inhibit both di- and trimethylation subtly. Their study suggested that interaction between 
various subunits within the Set1 Complex is crucial for effective enzymatic activity. Soares et al. 
(2014) have found that Set1 is stabilized by H3K4 methylation and are regulated by transcription. 
They deleted various regions of the SET1 gene and generated different mutants and analyzed the 
role of different domains within the Set1 that are responsible for specific functions. 
Takahashi et al. (2011)  reconstituted fully functional yeast Set1/COMPASS in vitro and identified 
the least possible subunits that are participated in H3K4 methylation. They have used techniques 
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such as Three-dimensional (3D) cryo-EM reconstructions of the core yeast complex, in 
combination with other techniques such as immunolabeling and two-dimensional (2D) EM 
analysis of the individual subcomplexes.  
 
1.7 Cell cycle and Nrm1 protein: 
In eukaryotes, cell proliferation is mediated through a four-step cycle, known as the cell cycle 
which consists of the G1 phase, S phase, G2 phase, and M phase (Massagué, 2004). When the 
cell commits to division, it enters the first gap phase G1. S is the synthetic phase in which cells 
synthesize DNA and other molecules needed for division. Then the second gap phase G2 which 
occurs between S and M phases. Basically, G1 and G2 gap phases repair the DNA damage and 
check the replication errors. The M phase in which chromosomes get separated and a cell divides 
into two daughter cells (Massagué, 2004). The cell cycle is controlled by the regulatory network 
of various cellular components and transcription factors. The G1–S transcriptional network is 
engaged in two important features of cell cycle regulation: control of cell cycle progression and 
maintenance of genome stability (Bertoli et al., 2013). In budding yeast, there exist the series of 
transcriptional factors that activate or repress the expression of the consecutive group of genes. 
This group of genes is functionally linked and work in coordination with each other (McInerny, 
2016). Many of these transcription factors are evolutionarily conserved with similar proteins 
across the species. In budding yeast, the expressions of G1-S genes are regulated by MBF and SBF 
transcriptional factors (Travesa et al., 2012). SBF mainly activates the genes which are involved 
in membrane synthesis and budding whereas MBF activates the genes required for DNA 
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replication and repair (Bähler, 2005). During the cell cycle, the transcriptional co-repressors, 
Whi5 and Nrm1, bind to SBF  and MBF respectively and regulate them (De Bruin et al., 2008). In 
humans, G1-S transcription is regulated by the E2F family of proteins (Bertoli et al., 2013).  
 
1.8 DNA replication stress: 
DNA replication which peaks at the S phase of the cell-division cycle is essential for the accurate 
genome duplication and successive transfer to daughter cells (Mazouzi et al., 2014). DNA 
replication always begins at specific sequences in a genome called replication origin. In yeast, 
there are around 400 replication origins (Leonard and Méchali, 2013). At the replication origin, 
two Y-shaped structures are formed called replication forks which move in opposite directions as 
replication proceeds (Nelson et al., 2008). Replication forks utilize deoxynucleoside triphosphates 
(dNTPs)  for the chain elongation. When the replication fork progression is slowed down or 
hindered it is called as genotoxic stress or replication stress. Replication stress can halt the DNA 
replication and incompletely replicated DNA can lead to genomic instability (Zeman and 
Cimprich, 2014). Replication stress can occur from endogenous sources (such as overexpression 
of oncogenes, the formation of DNA-RNA hybrids, DNA lesions, the formation of secondary DNA 
structures and so on) and exogenous sources (such as UV exposure, exposure to DNA-damaging 
agents, etc.) (Magdalou et al., 2014, Zeman and Cimprich, 2014). One of the ways the replication 
stress occurs is when there is a low dNTPs level in the dividing cell. The cell cycle checkpoints 
make sure that there is enough dNTPs level to move further in the cell cycle into the next phase 
of DNA replication. The level of dNTP is monitored by the DNA replication checkpoint and if there 
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is enough dNTP level then it moves to S-phase if not the cell remains in the G1 phase until the 
replication stress is resolved (Niida et al., 2010).  
 
1.9 Nrm1 and replication stress: 
During the cell cycle, expression of G1/S genes needed for early cell cycle functions is regulated 
by MBF and SBF transcription factors. Cells have developed the checkpoint mechanisms to check 
the orderly progression of the cell cycle events and to ensure genetic stability during the odd 
conditions like DNA damage and DNA replication stress. In Saccharomyces cerevisiae, the DNA 
replication checkpoint which identifies the DNA replication stress, mainly copes up with the help 
of checkpoint effector protein kinase, Rad53 (Travesa et al., 2012). Both DNA Damage repair 
genes and Cell Cycle genes exert their function during the replication stress. One of the 
mechanisms for the transcriptional response to replication stress in budding yeast is by the 
downstream regulation of Rad53 through Dun1 protein kinase (Travesa et al., 2012). Dun1 
protein kinase inactivates the transcriptional repressor Crt1 by phosphorylation. This inactivation 
of Crt1 helps in promoting the expression of various DNA damage repair genes including  
ribonucleotide reductase-encoding genes. Ribonucleotide reductase is a key enzyme responsible 
for the synthesis of deoxyribonucleotides (dNTPs) (Xie et al., 2014). These dNTPs are utilized in 
the synthesis of DNA during DNA replication or DNA repair. Another pathway in response to DNA 
replication stress is Rad53 directly phosphorylates Nrm1, which restrains its binding with MBF-
regulated promoters, which mediates the expression of MBF-dependent genes (Travesa et al., 
2012). 
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Fig. 1.3: Nrm1 Phosphorylation Mediates G1/S Transcription Upon Activation of Replication Checkpoints. 
Figure adapted from (Smolka et al., 2012). Both DNA damage repair (DDR) genes and Cell Cycle (CC) genes exert 
their function during the replication (genotoxic) stress. One of the pathways involves the downstream 
regulation of Rad53 through Dun1 protein kinase that inactivates the transcriptional repressor Crt1 by 
phosphorylation. Another pathway involves Rad53 directly phosphorylating the transcriptional co-repressor 
Nrm1, which restrains its binding with MBF. 
 
1.10 What could potential methylation of Nrm1 entail? 
Set1 Complex is composed of eight subunits, which are: Set1, Sdc1, Bre2, Swd2, Swd1, Swd3, 
Shg1, and Spp1,  out of which Set1 is required to maintain the integrity of the complex (Roguev 
et al., 2001). Set1C/COMPASS methyltransferase has various functions which include; mono, di, 
and trimethylation of H3K4, RNA polymerase II elongation factor, maintenance of telomere 
length, transcriptional silencing of mating-type loci and telomeres, meiotic S-phase onset during 
DNA replication, and methylation of kinetochores for mitotic chromosome segregation (Dehé et 
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al., 2006, Dehe and Geli, 2006, Krogan et al., 2002, Ng et al., 2003, Sollier et al., 2004, Zhang et 
al., 2005). 
 
Fig. 1.4: Different subunits of Set1 Complex 
There is the protein-protein interaction within the Set1 complex (Dehé et al., 2006). The 
interaction within the components of the Set1 Complex determines its stability, its integrity, and 
the H3K4 methylation. One study by Zhang et al. (2005) has shown that Set1C can also interact 
with non-histone proteins. My research is to characterize a possible function for the interaction 
between Set1 and a non-histone protein Nrm1.  
From the previous study, it has been found that yeast two-hybrid system with Swd1 identifies 
Nrm1, and the interaction domain has also been determined which lies in the region between 60 
to 190 residues in Nrm1 protein (B. Dichtl unpublished results). Swd1 is a subunit of the Set1 
complex. The Set1C (or Swd1) interaction domain in Nrm1 is found to be similar to that in Histone 
H3 (see Fig 1.5). Those findings led to the assumption that Set1 might methylate Nrm1 in vivo 
and the methylation site probably at Lysine 118 (K118) residue. 
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Fig. 1.5: Set1C interaction domain in Nrm1. Nrm1 has a length of 249 amino acid residues. Nrm1 has a short 
destruction box motif near N-terminal shown in yellow. The Set1C interaction domain is shown in red. 
 
To the date, only one study has been carried out to observe the possible interaction of Set1 with 
non-histone substrates. A study by Zhang et al. (2005) showed the important functional link 
between Set1 and the kinetochore protein, Dam1. Aurora kinases are responsible for the 
organization of the kinetochore and are needed for normal chromosome segregation 
(Cheeseman et al., 2002). Ipl1, a member of the aurora kinase family, plays a role in the 
phosphorylation of Dam1. The important finding of their study was that the Set1 was needed for 
the methylation of conserved lysines in Dam1. Additionally, this Dam1 methylation was found to 
inhibit the Ipl1-mediated phosphorylation of neighboring serines which indeed disrupts the 
kinetochore integrity (Zhang et al., 2005). 
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Fig. 1.6 : Interaction of Set1 with non-histone proteins. (A) Interaction of Set1 and Dam1, which has been already 
studied (Zhang et al., 2005). (B) Possible interaction between Set1 and Nrm1, and the resulting potential 
consequences (B1) and (B2). 
 
My hypothesis is that Set1 possibly methylates Nrm1 in a similar way as it methylates Dam1. 
Preliminary data shows that Set1 does methylate Nrm1 in vitro (B Dichtl, unpublished).  But does 
Set1 methylate Nrm1 in vivo? And does this methylation on Nrm1 impact on the phosphorylation 
of Nrm1?  
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The checkpoint effector protein kinase, Rad53 phosphorylates Nrm1 (Travesa et al., 2012). The 
phosphorylated Nrm1 cannot bind to MBF thus dissociates from MBF. The methylation on Nrm1 
by Set1 can potentially inhibit this phosphorylation and can keep the association of Nrm1 with 
MBF, which impacts on cell cycle progression during the G1/S phase. 
A study carried out by Ostapenko and Solomon (2011) suggests that Nrm1 is stabilized by the 
phosphorylation presumably carried out by the cyclin-dependent protein kinase, Cdc28. Nrm1 
methylation possibly affect the function of Cdc28 which ultimately affects the Nrm1 protein 
stability. 
 
1.11 Approaches to study protein-protein interactions 
and protein stability: 
Interactions between the proteins are vital functions of cellular mechanisms. Various protein 
complexes have a role in processes like the synthesis of DNA, transcriptional activation, protein 
translation and localization, and cell signaling. Various methodologies have been developed to 
understand protein-protein interactions ranging from biochemical techniques like affinity 
chromatography and co-immunoprecipitation to molecular genetics techniques like the yeast 
two-hybrid system.  
The protein-protein interactions can be further characterized by observing the protein stability 
in one of the interacting proteins. Protein stability can be determined by using the techniques 
like pulse-chase analysis and cycloheximide assay.  
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1.11.1 Cycloheximide assay to determine protein stability 
Cycloheximide is a naturally occurring fungicide that inhibits  protein synthesis in yeast and higher 
eukaryotes. Cycloheximide treatment inhibits a wide range of protein synthesis and is not specific 
(McMahon, 1975). Translation inhibition by cycloheximide treatment is found to interfere with 
other cellular metabolisms (Zhang et al., 2007). The mechanism by which cycloheximide inhibits 
protein synthesis hasn’t been clearly figured out yet. However studies suggest that cycloheximide 
binds to the E-site of the 60S ribosomal unit and impedes with deacetylated tRNA and therefore 
halts the translation elongation (Pestova and Hellen, 2003). The half-lives of short-lived proteins 
can be determined by using cycloheximide. In a typical cycloheximide assay, firstly cycloheximide 
is added to the growing culture and the cells are harvested at different time-points followed by 
Western Blot analysis. 
 
1.11.2 Co-immunoprecipitation: 
Co-immunoprecipitation (Co-IP) is a useful technique that can be used to detect  specific protein-
protein interactions. It is only possible to detect the protein-protein interactions by co-
immunoprecipitation if the potential binding partner is known and those partners can be 
detected by Western blot (Gerace and Moazed, 2014). In a conventional Co-IP, the desired 
protein that is bound to a target protein is captured indirectly from a cell lysate using a target 
protein-specific antibody (Berggård et al., 2007). By the application of protein A or protein G 
covalently bound to sepharose or agarose beads, the antibody is then immobilized . The beads, 
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the antibody, the target protein, and the protein which is bound to the target protein are eluted 
by washing. These protein complexes can be then analyzed to detect new binding partners, to 
study the kinetics and function of the target protein (Berggård et al., 2007). 
 
 
1.12 Objectives: 
1.12.1 Research Question: 
Preliminary data have revealed the unexpected genetic interaction between Set1 histone 
methyltransferase and Nrm1 protein, which regulates the cellular response to replication stress 
(B. Dichtl, unpublished). This observation suggests that there may be a functional link between 
the regulation of chromatin structure and the DNA replication checkpoints which is an important 
step in eukaryotic cell cycles. 
So, the research question is: Is there a requirement for Set1 histone methyltransferase to facilitate 
the function of co-repressor Nrm1 in the regulation of replication stress? 
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1.12.2 Specific Aims: 
The project has 3 major aims, which are as follows: 
I. Is there a requirement for Set1 in the determination of normal Nrm1 protein levels? 
II. Does Set1 histone methyltransferase or its activity impact on Nrm1 protein stability? 
III. Does the interaction of Nrm1 and Set1 change in the presence of replication stress?  
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CHAPTER II: MATERIALS AND METHODS 
2.1 Materials: 
2.1.1 General chemicals, buffers, media & reagents: 
Solutions used in this study were prepared using ultrapure water prepared by Milli-Q® Integral 
water purification system (Australia). Standard autoclave or 0.22µm filtration methods were 
used to sterilize the prepared solutions and media. Almost all the chemicals were supplied from 
Amresco Biochemicals and Life Science (Australia) unless otherwise stated. Invitrogen Bolt Bis-
Tris precast protein gels and Bolt MES buffers were purchased from Thermo Fisher Scientific. 
 
2.1.2 Primary and Secondary Antibodies: 
Commercially available antibodies were used. All the primary and secondary antibodies were 
purchased from Abcam Australia.  
 
2.1.3 Plasmids and Yeast strains: 
All the yeast (S. cerevisiae) strains and plasmids were provided by Dr. Bernhard Dichtl (B. Dichtl, 
unpublished materials). Plasmids used in my study are listed below in Table 2.1. 
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Table 2.1: List of plasmids used in the study 
S.N. Plasmids Description Marker 
1 WT NRM1-HA wild type HA-tagged NRM1 LEU2 
2 ΔN- NRM1-HA deletion of destruction box that destabilizes the Nrm1 
protein 
LEU2 
3 NRM1-AAA-HA Set interaction domain K116TK118QT is cis-mutated to 
A116AA118QT 
LEU2 
4 WT GAL1p- 
NRM1-HA 
wild type HA-tagged NRM1 with GAL1 inducible promoter LEU2 
5 GAL1p- NRM1-
AAA-HA 
AAA mutated HA-tagged NRM1 with GAL1 inducible 
promoter 
LEU2 
6 ProtA-NRM1 Protein A tagged NRM1 LEU2 
7 HA3-SET1 3 X HA tagged SET1 URA3 
8 ProtA empty Protein A empty plasmid LEU2 
9 URA3 empty URA3 empty plasmid URA3 
 
Two yeast strains were used in this study which are:  
1) Δnrm1: single mutant, carries a chromosomal deletion of the NRM1 gene in a haploid strain 
2) Δnrm1 Δset1: double mutant, carries the chromosomal deletions of the NRM1 gene and the 
SET1 gene in a haploid strain 
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2.2 Methods:  
2.2.1 Microbial culture and handling 
Aseptic techniques were followed while handling yeast and bacterial cultures. The working area 
was disinfected with 70% ethanol before proceeding any experiments that involved the 
manipulation of microbes. Microbial works were carried out near the open flame or inside the 
biosafety cabinet. Sterile inoculating loop or pipette tips were used to pick up and transfer 
colonies from culture plates.  
 
2.2.2 Yeast Culture Method 
2.2.2.1 Yeast growth medium: 
Liquid Media: Yeast cultures were grown in YPD medium containing 1% (w/v) yeast extract, 2% 
(w/v) peptone, 2% (w/v) glucose or amino acid drop out Synthetic Dextrose (SD) medium 
containing 0.67% (w/v) yeast nitrogen base, approximately 0.07% (w/v) amino acid drop out mix 
and 2% (w/v) glucose. 
Solid Media: Solid YPD and SD media were prepared in the similar manner to liquid media except 
in solid media, 2% (w/v) agar A was added prior to autoclaving. After autoclaving, 2% (w/v) 
glucose was added and mixed and poured onto the Petri dishes/plates.  
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2.2.2.2 Yeast growth condition and long-term storage: 
Yeast strains were generally grown at 300C with additional shaking at 150-250 rpm. For short 
term usage, yeast cultures were streaked on YPD or SD plates, wrapped with parafilm, and grown 
for 2 days at 300C. Fresh yeast cultures were used for all the experiments by routinely re-streaking 
on fresh plates a few days prior to carrying out the experiment. For long-term storage, a loop of 
freshly grown cells was taken and put into the Eppendorf tube containing 2 X volume of YPD 
containing 50% (w/v) glycerol, and the resulting mixture was stored at -800C. 
 
2.2.2.3 Yeast cell harvest for protein extraction: 
A single colony of the sample from the fresh culture plates was taken and inoculated into 50 ml 
YPD or SD selective media, and pre-culture was set up in a 250 ml flask and shaken at 300C 
overnight. The next day, optical density at wavelength 600nm (OD600nm) was measured. The 
dilution needed to set up the main culture to an OD of 0.15 was calculated and the final volume 
of 50 ml of the media (main culture) was set up. The main culture was shaken and grown at 300C 
for 4-6 hours until the OD reached 0.5. Approximately, at OD ~0.5, cells were harvested. To 
harvest the cells, first, the culture was transferred to a 50 ml falcon tube and was centrifuged at 
3000 rpm for 5 minutes. The supernatant was then removed, and cell pellets were resuspended 
with distilled water and 1ml of the resuspended cell pellets was transferred into an Eppendorf 
tube and centrifuged at 13,000 g for 1 minute. The supernatant was removed, and the cell pellets 
were stored at -200C. 
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2.2.2.4 Culture Disposal: 
S. cerevisiae cultures were first treated with an equal volume of 2.5% Sodium Hypochlorite 
solution and kept overnight. Next day, disinfected cultures were disposed of through the drain. 
 
2.2.3 Yeast Transformation Method 
Yeast transformation was performed by the method described by Gietz and Schiestl (2007) with 
slight modifications.  
TO PREPARE YEAST COMPETENT CELLS: Yeast strains were cultured in YPD medium overnight at 
300C. The next day, main cultures were set up from pre-cultures and grown till the OD reached 
~0.5. Then, the cultures were collected in 50 ml falcon tubes and centrifuged at 3000 rpm for 5 
minutes. The supernatant was poured off and the cells were washed with 30 ml of sterile water 
and again centrifuged at 3000 rpm for 5 minutes. The supernatant was poured off. Cell pellets 
were resuspended in 3 ml sterile water. After that, 1 ml suspension was transferred to Eppendorf 
tube and centrifuged at 13000 g for 1 minute. The supernatant was discarded. Cells were 
resuspended in 1 ml TE-LiAc solution (10 mM Tris-HCl, pH 8.0, with 1mM EDTA and 0.1M lithium 
acetate) and centrifuged again at 13000 g for 1 minute. The supernatant was discarded. Cell 
pellets were resuspended in 200 μl of TE-LiAc solution. This suspension was used as competent 
cells for the transformation.  
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TRANSFORMATION MIXTURE: For transformation, the following components were added in an 
Eppendorf tube: 
i.  Competent cells: 50 μl 
ii. Plasmid DNA: 3 μl  
iii. Herring Sperm DNA: 2 μl (pre-heated at 950C for 5 minutes) 
iv. PEG-TE-LiAc solution: 300 μl (45% (w/v) Polyethylene glycol 4000 added in TE-LiAc solution) 
 
A negative control containing no plasmid was also prepared. The transformation mix was 
vortexed and then incubated at 300C for 30 minutes with shaking. It was followed by heat shock 
for 15 minutes at 42°C. After that, it was spun down for 30 seconds at 13000 g. The supernatant 
was removed. Cell pellets were resuspended in 1 ml of sterile water and again spun down for 1 
minute at 13000 g. The supernatant was discarded, and the pellets were resuspended in 100 μl 
sterile water. Finally, transformed cells were plated on appropriate SC drop-out medium and 
grown at 300C for 2-3 days or until fully grown colonies were observed. Colonies were then picked 
and streaked for purity. 
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2.2.4 Methods for protein extraction from yeast cells 
2.2.4.1 Protein extraction by using Zirconia/Silica Beads 
Cell pellets obtained by harvesting the yeast cells were resuspended in 500 μl of lysis buffer 
IPP150 (10 mM Tris–HCl pH 8.0, 150 mM NaCl, 0.1 % NP40) containing protease inhibitors (PI). 
An equal volume (approximately 500 μl) of zirconia/silica beads was added. This method was 
carried out on the ice. Microcentrifuge tube containing the mixture was then vortexed for 5 
cycles, 30 seconds vortex and 30 seconds rest for cooling on ice. The microcentrifuge tube was 
then punctured with a sterile needle and placed on top of a new microcentrifuge tube and was 
pulse spun using a microcentrifuge. The flow-through was collected and was spun at 14000 g for 
10 minutes at 40C in a cooling centrifuge. 250 μl of supernatant was transferred into a new tube 
and centrifuged again at 14000 g for 10 minutes at 40C. 200 μl of supernatant (lysate) was 
transferred into another tube and was stored at -200C for further analysis. Protein concentrations 
of the lysates were determined by the Bradford method (Bradford, 1976). 
 
2.2.4.2 Protein extraction by Freezing and grinding 
Some proteins can be denatured when extracted by Zirconia/Silica Beads method. So, for more 
sensitive experiments like co-immunoprecipitation, lysates were prepared by freezing and 
grinding methods. Cell pellets were resuspended in 5 ml lysis buffer IPP150 containing protease 
inhibitors (PI) and 1mM Dithiothreitol (DTT). Liquid nitrogen was slowly dropped onto the 
suspension which forms small frozen drops. The steel grinding jar and ball were pre-cooled using 
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liquid nitrogen. The frozen cells were cryogenically ground by using Mixer Mill MM 400 (RETSCH, 
Germany), for 3 cycles- 30 seconds grinding and 2 minutes rest for cooling in liquid nitrogen. The 
powder was collected and stored at -800C for further analysis. 
 
2.2.5 SDS PAGE, Western blotting, and Immunodetection: 
SDS PAGE:  
SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) is an electrophoresis 
technique that allows protein separation by mass. Protein concentrations of the lysates were 
measured, and samples were prepared in microcentrifuge tubes making the equal concentration 
of proteins in all the samples by diluting the samples with IPP150+PI. To each sample, 6 μl of 4X 
Bolt™ LDS Sample Buffer and 3 μl of 10X Bolt™ Sample Reducing Agent were added making the 
final volume 39 μl. The sample mix was then heated for 10 minutes at 700C.  Invitrogen Mini Gel 
Tank electrophoresis chamber system was set up and precast gels (Bolt™ 4 to 12%, Bis-Tris, 1.0 
mm, Mini Protein Gel, 10-well) were used for electrophoresis. 1X Bolt™ MES SDS Running Buffer 
was used as a running buffer. 5 μl of PageRuler Prestained Protein Ladder was loaded in the first 
well.  Then, 25 μl of the samples were loaded into the other wells. Then a constant voltage of 150 
Volts was applied to the gel tank and it was run for 45-60 minutes until the dye front reached to 
the bottom of the gel. 
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WESTERN BLOT:  
PVDF membrane was soaked in methanol for 30 seconds. Foam pads and filter papers were 
soaked in transfer buffer (25 mM Tris, 192 mM Glycine, 5% (v/v) methanol, pH ~8.3) for at least 
30 seconds.  The cassette holder (Invitrogen™) containing foam pads, sheets of filter papers, gel, 
and PVDF membrane, was set up and placed in the transfer tank and was filled with transfer 
buffer. The electric field was applied in the cold room for 90 minutes at a constant voltage of 20 
V. After the transfer was completed, the blot was isolated and put in Ponceau S Staining Solution 
(0.1%(w/v) Ponceau S in 5%(v/v) acetic acid). Ponceau staining helps to detect the transferred 
proteins on the blot and can also be useful to check the equivalent loading.  
 
IMMUNODETECTION:  
The blot was then washed with sterile water and shaken for 1 hour on the rocker by adding 5% 
(w/v) skim milk (in TBST buffer). After that, the blot was rolled and put in the falcon tube 
containing 1:1000 dilution of primary antibody and 5% skim milk solution. The tube containing 
the blot was gently agitated overnight on the roller in the cold room at 40C. The next day, the 
blot was taken out and was washed 3 times for 10 minutes with TBST (Tris-Buffered Saline with 
Tween20: 20 mM Tris, 150 mM NaCl, 0.1% (w/v) Tween 20, pH=7.5). Then the blot was incubated 
for 1-2 hours at room temperature in the HRP-conjugated secondary antibody and 5% skim milk 
solution in 1:2000 dilution. Afterward, the blot was washed 3 times for 10 minutes with TBST. 
The blot was then treated with 2+2ml of Immobilon Western Chemiluminescent HRP Substrates 
and was visualized using a Biorad ChemiDoc MP Imaging System. 
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STRIPPING AND REPROBING:  
The blot was immersed in stripping buffer (100 mM 2-Mercaptoethanol, 2% (w/v) SDS, 62.5 mM 
Tris-HCl pH 6.7) and incubated at 500C- 700C for 30 minutes with seldom agitation. Subsequently, 
the blot was washed 2 times for 10 minutes in TBST. Then, the blot was blocked in 5% skim milk 
in TBST for 1 hour at room temperature. The immunodetection was repeated using a new 
antibody. 
 
2.2.6 Cycloheximide assay to determine protein half-life 
The half-life of protein was determined by using cycloheximide assay. Pre-cultures were set in 
YPGal (1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) galactose) media.  Main cultures were 
grown in 100 ml YPGal with initial OD set to 0.2 and grown till the OD reached 0.6. Then, 1 ml of 
1% (w/v) cycloheximide solution was added to the culture and shaken for 5 minutes. After that, 
15 ml aliquot was taken in a falcon tube and the timer was started considering it as T0. 
Subsequently, the aliquot was placed on ice and spun down immediately at 40C at 3000 rpm for 
5 minutes. After taking out T0 aliquot from the main culture, 15 ml of 20% (w/v) glucose solution 
was added and shaken. 15 ml aliquots were taken at different time points: 10,20,30,40, and 60 
minutes (T10, T20, T30, T40, and T60) and were centrifuged at 3000 rpm for 5 minutes. Thus obtained 
cell pellets were stored immediately at -800C.  
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Then protein extraction was done by using Zirconia/Silica Beads homogenization method. SDS-
PAGE and Western blotting were done for various samples and finally immunodetection by using 
anti-HA and anti-Tubulin antibodies.  
 
2.2.7 Co-Immunoprecipitation 
CELL CULTURE AND LYSIS:  
100 ml of each sample pre-cultures were grown in SD-Leu-Ura media at 300C overnight. The next 
day, main cultures were set in 1-liter fresh SD-Leu-Ura media to OD 0.2 and grown for the next 
10-14 hours to reach approximately 8-10 OD. Then the cells were harvested by centrifuging at 
8000 rpm for 10 minutes at 40C. The supernatant was discarded, pellets were resuspended in 100 
ml water, and centrifuged again. After removing the supernatant, pellets were resuspended in 
10ml IPP150 buffer containing 1mM Dithiothreitol (DTT). The mixture was transferred into 15 ml 
falcon tubes and centrifuged at 3000 rpm for 10 minutes at 40C. The supernatant was discarded, 
and cell pellets were resuspended in 5 ml IPP150 buffer containing Protease Inhibitors (PI) and 
were frozen as drops in liquid nitrogen. Cells were then lysed by using the Freezing and grinding 
method with the use of liquid nitrogen and lysates were stored as a powder at -800C. 
 
EQUILIBRATING IgG-SEPHAROSE: 
About 600 μl IgG-Sepharose (lgG Sepharose® 6 Fast Flow, from GE Healthcare) slurry was taken 
in a 15 ml falcon tube. To that, 10 ml of IPP150 buffer was added and spun at 1500 rpm for 5 
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minutes and this step was repeated three times. After removing the supernatant on the third 
round, packed sepharose was resuspended in 4 ml IPP150 buffer containing PI. 
 
PREPARING SAMPLES FOR BINDING: 
The stored powdered lysates were thawed on ice. Then, the samples were brought to 
comparable volume by adding IPP150 with PI. 15 ml of each sample were transferred to Correx 
tubes and were centrifuged at 10000 rpm at 40C for 30 minutes. After centrifugation, a blue tip 
was used to remove the upper lipid layer and ~1 ml of the supernatant having lipid-rich fractions 
was also removed using another fresh tip. Only the clear lysate was taken, and pellet debris was 
avoided. 10 ml of clear lysate was taken in a 15 ml tube and was used for binding. 200 μl of the 
sample was reserved as the INPUT sample and was stored at -200C. 
 
BINDING: 
1 ml of equilibrated IgG-sepharose slurry was added to 10 ml of sample (~100 μl beads/ sample 
of packed bed volume was used) and was put on a roller at 40C for 2 hours and left for binding. 
After that, it was centrifuged at 1500 rpm for 5 minutes at 40C. The unbound supernatant was 
taken out and out of which 200 μl was reserved as the UNBOUND sample and stored at -200C. 
Bound sample with sepharose beads was washed 3 times with 10 ml IPP150 on a roller for 20 
minutes and after each wash, centrifuged at 1000 rpm for 1 minute and the supernatant was 
removed. After the final wash, the supernatant was removed completely. To approximately 100 
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ml sepharose bound sample, 100 μl 6X SDS loading buffer (600mM Tris-HCl, pH=6.8, 12% (w/v) 
SDS, 30% Glycerol (v/v), 0.03% Bromophenol blue dye , 5% (v/v) β-mercaptoethanol ) was added 
and heated at 950C for 5 minutes. The supernatant was transferred into the Eppendorf tube and 
stored at -200C as the BOUND sample. Before loading the samples into the gel, they were spun 
down and 30 μl was taken from the top.  
SDS-PAGE and Western blotting were done for various BOUND and INPUT samples and finally 
immunodetection by using the anti-HA antibody. 
 
 
2.3 Statistical analysis 
All the experiments were performed twice using at least two biological replicates. In Western 
Blotting, the main technique used in my study, there is no real statistical analysis involved. 
However, the obtained results were analyzed using BioRad ImageLab software. From the data 
generated by ImageLab software, the average(mean) value of two replicates was calculated and 
represented as Mean ± Standard Deviation. 
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CHAPTER III: RESULTS 
3.1 Set1 is required in the determination of normal Nrm1 
protein levels  
Two yeast strains were transformed using three plasmids as follow: 
Yeast strains: 1) Δnrm1 
                         2) Δnrm1 Δset1 
Gene deletion is denoted with the Greek character, Δ. Δnrm1 strain carries a chromosomal 
deletion of the NRM1 gene in a haploid strain. Similarly, Δnrm1 Δset1 strain is a double mutant 
that carries the chromosomal deletions of the NRM1 gene and the SET1 gene in a haploid strain. 
 Plasmids:    a) WT NRM1-HA 
                b) ΔN- NRM1-HA 
          c) NRM1-AAA-HA 
Please see, Table 2.1 for the details about the plasmids used. All the three plasmids contain HA-
tagged  NRM1 so Nrm1 protein can be detected by using an anti-HA antibody while analyzing the 
blots. WT NRM1-HA plasmid was the wild type, ΔN- NRM1-HA had its destruction box deleted 
and, NRM1-AAA-HA had  K116TK118QT sequence mutated to A116AA118QT. 
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In total, 6 transformants were obtained which were wt-nrm1, wt-nrm1 ∆set1, ∆N-nrm1, ∆N-
nrm1 ∆set1, nrm1-AAA, and nrm1-AAA ∆set1. Cell lysates were prepared, and SDS-PAGE and 
Western Blotting were carried out. Anti-HA and anti-α--Tubulin antibodies were used and the 
immunoblots results are represented in Fig 3.1.1. In ∆set1 transformants (which do not have SET1 
gene),  weaker signals of Nrm1 band were observed as compared to the transformants having 
the SET1 gene. 
 
Fig 3.1.1: Immunoblot results with anti-HA and anti-α-Tubulin antibodies. Nrm1-HA has molecular weight 
~38kDa and α-Tubulin ~50 kDa. Lysates prepared from six different transformants, each transformant having 
two biological replicates, so in total twelve lysates were loaded into Bolt™ precast gel (4 to 12%, Bis-Tris, 1.0 
mm, 15-well) followed by Western Blotting. First, anti-HA antibody was used which detects HA-tagged Nrm1 
protein. The blot was then stripped and reprobed with anti-α-Tubulin antibody which was used as a loading 
control as well as used for quantification of Nrm1 protein levels. 
 
By analyzing the immunoblots with BioRad ImageLab software, the relative band intensities of 
Nrm1 to α-Tubulin were calculated as represented in figure 3.1.2. Relative Nrm1 protein 
abundance in the wt-nrm1 sample was set to 100% and in-reference to wt-nrm1, other samples 
were compared. ∆N-nrm1 transformant had the highest Nrm1 protein abundance, followed by 
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wt-nrm1 and nrm1-AAA. ∆N-nrm1 ∆set1 was found to have a high Nrm1 protein abundance 
despite having a deleted SET1 gene. nrm1-AAA ∆set1 had the lowest Nrm1 expression among all. 
The lower Nrm1 protein levels in ∆set1 mutants than the wild-type cells suggest that Set1 is 
required for the determination of the normal Nrm1 levels. 
 
 
Fig 3.1.2: Nrm1 protein abundance in different transformants. Nrm1 protein abundance was determined by 
the quantification of immunoblot results obtained in Fig 3.1.1. Band intensity ratios of Nrm1 relative to α-
Tubulin were calculated by using BioRad ImageLab software. Nrm1 abundance in wt-nrm1 was set to 100% and 
the expressions of Nrm1 protein levels in other lysates were compared with wt-nrm1. The mean values of 
protein expression levels of two replicates were calculated and expressed as Mean ± standard deviation.  
 
3.2 Set1 impacts on Nrm1 protein stability 
Two yeast strains were transformed using two plasmids as follow: 
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Yeast strains: 1) Δnrm1 
                         2) Δnrm1 Δset1 
Plasmids:    a) WT GAL1p- NRM1-HA 
                b) GAL1p- NRM1-AAA-HA 
          
Please see, Table 2.1 for details about the plasmid used. Besides having HA tags, both the 
plasmids contained galactose-inducible promoters (GAL1p) in which the NRM1 promoter was 
replaced with the GAL1/10 promoter that can be induced and repressed. Four transformants 
were obtained which were; wt-nrm1, nrm1-AAA, wt-nrm1 Δset1, and nrm1-AAA Δset1. The 
cultures were grown in the media containing galactose which induces the transcription of GAL1p 
containing the NRM1 gene. The immunoblot results of various lysates, that were obtained by 
cycloheximide assay at different time points(0, 10, 20, 30, 40, and 60 minutes), are shown in the 
figures below. This experiment was repeated two times using two biological replicates. Western 
blot results show that Nrm1 protein degrades rapidly over a short time. α-Tubulin not only acts 
as a loading control but also useful in finding relative protein concentration, which helped to 
determine the relative concentration of degrading Nrm1 protein. The rates of protein 
degradation in wt-nrm1 and nrm1-AAA transformants were found to be slower than that of wt-
nrm1 Δset1 and nrm1-AAA Δset1 transformants indicating that Set1 affects the Nrm1 stability.  
The immunoblot results of four transformants and the quantification of immunoblot results are 
shown in the figures below from Fig 3.2.1 to Fig 3.2.8: 
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Fig 3.2.1: wt-nrm1 transformants immunoblot results with anti-HA and anti-α-Tubulin antibodies. Nrm1-HA has 
molecular weight ~38 kDa and α-Tubulin ~50 kDa. The plasmids used for the transformation contain galactose-
inducible promoter (GALp), so the cultures were grown in YPGal media containing 2% (w/v) galactose which induces 
the transcription of GAL1p containing NRM1 gene. Before harvesting the cells, 2% (w/v) glucose was added which 
represses the transcription. And, 1% (w/v) cycloheximide solution was added which inhibits the translation. This 
initial time point was considered as T0. Cells were harvested at different time points at 0,10,20,30,40, and 60 minutes 
after adding cycloheximide. Cell lysates were prepared, and SDS-PAGE and western blotting were carried out using 
anti-HA and anti-α-Tubulin antibodies. Nrm1 protein degradation was observed over the time. 
  
Fig 3.2.2: Nrm1 degradation over time in wt-nrm1 transformants: Nrm1 protein abundance was determined by the 
quantification of immunoblot results obtained in Fig 3.2.1. Band intensity ratios of Nrm1 relative to α-Tubulin  were 
calculated by using Biorad ImageLab software. Y-axis represents the Nrm1 protein abundance in percentage whereas 
the X-axis represents time in minutes. Sample taken at time point (T0) was set to 100% and the expressions of Nrm1 
protein levels in other lysates were compared with (T0). The half-life of Nrm1 was calculated from the graph. 
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Fig: 3.2.3: nrm1-AAA transformants immunoblot results with anti-HA and anti-α-Tubulin antibodies. Nrm1-HA 
has molecular weight ~38 kDa and α-Tubulin ~50 kDa. The plasmids used for the transformation contain galactose-
inducible promoter (GALp), so the cultures were grown in YPGal media containing 2% (w/v) galactose which induces 
the transcription of GAL1p containing NRM1 gene. Before harvesting the cells, 2% (w/v) glucose was added which 
represses the transcription. And, 1% (w/v) cycloheximide solution was added which inhibits the translation. This 
initial time point was considered as T0. Cells were harvested at different time points at 0,10,20,30,40, and 60 minutes 
after adding cycloheximide. Cell lysates were prepared, and SDS-PAGE and western blotting were carried out using 
anti-HA and anti-α-Tubulin antibodies. Nrm1 protein degradation was observed over the time. 
 
Fig 3.2.4: Nrm1 degradation over time in nrm1-AAA transformants: Nrm1 protein abundance was determined by 
the quantification of immunoblot results obtained in Fig 3.2.3. Band intensity ratios of Nrm1 relative to α-Tubulin  
were calculated by using Biorad ImageLab software. Y-axis represents the Nrm1 protein abundance in percentage 
whereas the X-axis represents time in minutes. Sample taken at time point (T0) was set to 100% and the expressions 
of Nrm1 protein levels in other lysates were compared with (T0). The half-life of Nrm1 was calculated from the graph. 
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Fig 3.2.5: wt-nrm1 Δset1 immunoblot results with anti-HA and anti-α-Tubulin antibodies. Nrm1-HA has molecular 
weight ~38 kDa and α-Tubulin ~50 kDa. The plasmids used for the transformation contain galactose-inducible 
promoter (GALp), so the cultures were grown in YPGal media containing 2% (w/v) galactose which induces the 
transcription of GAL1p containing NRM1 gene. Before harvesting the cells, 2% (w/v) glucose was added which 
represses the transcription. And, 1% (w/v) cycloheximide solution was added which inhibits the translation. This 
initial time point was considered as T0. Cells were harvested at different time points at 0,10,20,30,40, and 60 minutes 
after adding cycloheximide. Cell lysates were prepared, and SDS-PAGE and western blotting were carried out using 
anti-HA and anti-α-Tubulin antibodies. Nrm1 protein degradation was observed over the time. 
 
Fig 3.2.6: Nrm1 degradation over time in wt-nrm1 Δset1 transformants: Nrm1 protein abundance was determined 
by the quantification of immunoblot results obtained in Fig 3.2.5. Band intensity ratios of Nrm1 relative to α-Tubulin  
were calculated by using Biorad ImageLab software. Y-axis represents the Nrm1 protein abundance in percentage 
whereas the X-axis represents time in minutes. Sample taken at time point (T0) was set to 100% and the expressions 
of Nrm1 protein levels in other lysates were compared with (T0). The half-life of Nrm1 was calculated from the graph. 
P a g e  | 42 
 
 
Fig 3.2.7: nrm1-AAA Δset1 immunoblot results with anti-HA and anti- α-Tubulin antibodies. Nrm1-HA has 
molecular weight ~38 kDa and α-Tubulin ~50 kDa. The plasmids used for the transformation contain galactose-
inducible promoter (GALp), so the cultures were grown in YPGal media containing 2% (w/v) galactose which induces 
the transcription of GAL1p containing NRM1 gene. Before harvesting the cells, 2% (w/v) glucose was added which 
represses the transcription. And, 1% (w/v) cycloheximide solution was added which inhibits the translation. This 
initial time point was considered as T0. Cells were harvested at different time points at 0,10,20,30,40, and 60 minutes 
after adding cycloheximide. Cell lysates were prepared, and SDS-PAGE and western blotting were carried out using 
anti-HA and anti-α-Tubulin antibodies. Nrm1 protein degradation was observed over the time. 
 
Fig 3.2.8: Nrm1 degradation over time in nrm1-AAA Δset1 transformants: Nrm1 protein abundance was 
determined by the quantification of immunoblot results obtained in Fig 3.2.7. Band intensity ratios of Nrm1 relative 
to α-Tubulin  were calculated by using Biorad ImageLab software. Y-axis represents the Nrm1 protein abundance in 
percentage whereas the X-axis represents time in minutes. Sample taken at time point (T0) was set to 100% and the 
expressions of Nrm1 protein levels in other lysates were compared with (T0). The half-life of Nrm1 was calculated 
from the graph. 
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The half-life (T1/2) is the time required for a protein to degrade by 50%. Half-lives of Nrm1 from 
different samples were calculated using the graphs and shown in Table 3.1 below. wt-nrm1  was 
found to have the longest half-life of ~38 minutes which was followed by nrm1-AAA with the half-
life of ~30 minutes. On the other hand, wt-nrm1Δset1 and nrm1-AAAΔset1 transformants (which 
do not have SET1 gene),  have fairly lower half-lives than the wild type. nrm1-AAAΔset1 has the 
shortest half-life of ~15 minutes. 
 
Table 3.1: Half-life of Nrm1 protein in different samples. 
Transformants Half-life (in minutes) 
 Replicate 1 Replicate 2 Mean ± SD 
wt-nrm1 30.35 45.61 37.98 ± 7.63 
 
nrm1-AAA 29.50 30.78 30.14 ± 0.64 
wt-nrm1  Δset1 23.17 15.14 19.16 ± 4.02 
nrm1-AAA  Δset1 13.85 16.00 14.93 ± 1.08 
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3.3 Interaction between Nrm1 and Set1 changes in the 
presence of replication stress 
Δnrm1 Δset1 strain was co-transformed using the following combination of plasmids: 
Plasmids used for co-transformation: 1) ProtA-NRM1 + HA3-SET1 
                                                                    2) ProtA-NRM1 + URA3 empty 
                                                                    3) ProtA empty + HA3-SET1 
In total, 3 transformants were obtained which were ProtA-nrm1 + HA3-set1, ProtA-nrm1, and 
HA3-set1. Please see, Table 2.1 for the details about the plasmids used. Lysates were prepared, 
co-immunoprecipitation was done, and SDS-PAGE and Western blotting were carried out for 
various BOUND and INPUT samples. Hydroxyurea was used to induce replication stress in the 
yeast cells. Immunoblot result was obtained as shown in Fig. 3.3.1 below. In INPUT samples, Set1 
protein can be visible in all other 3 lysates except ProtA-nrm1. ProtA-nrm1 mutants don’t have 
SET1 so no band was observed as expected.  A similar result can be seen in BOUND samples as 
well. Signal can be observed in ProtA-nrm1 + HA3-set1 mutants.  The signal was found to be 
enhanced in Hydroxyurea (+HU) treated ProtA-nrm1 + HA3-set1 mutants indicating that there 
might be a possible involvement of Set1 to facilitate the function Nrm1 in the regulation of 
replication stress. 
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Fig 3.3.1: Immunoblot result of various samples after co-immunoprecipitation using an anti-HA antibody. The 
molecular weight of the Set1 protein is ~123 kDa. M represents the marker used. ProtA-nrm1 and HA3-set1 were 
used as controls. Before 1-2 hours of harvesting the cells, ProtA-nrm1 + HA3-set1(+HU) samples were treated with  
100mM hydroxyurea (HU). ProtA-nrm1 + HA3-set1(-HU) samples were not treated with hydroxyurea. INPUT samples 
were the lysates taken before performing Co-IP. BOUND samples were the lysates taken after Co-IP binding was 
done. 
 
(Note that, there are limitations to my Co-IP experiment. The Co-IP experiment was only carried 
out once. Due to the Covid-19 pandemic, my research was halted, and the Co-IP experiment 
couldn’t be repeated. For BOUND samples (see fig 3.3.1), ProtA-nrm1 and  HA3-set1 were used as 
negative controls. However, HA3-set1 also showed a band that might have occurred due to non-
specific binding.) 
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CHAPTER IV: DISCUSSIONS 
Set1 complex is a histone-modifying enzyme that catalyzes histone H3 lysine 4 (H3K4) 
methylation in yeast (Dehe and Geli, 2006). Nrm1 is an MBF-associated co-repressor involved 
during the G1/S transition of the cell cycle. Nrm1 binds to G1-specific promoters via MBF, 
repressing the MBF-dependent genes which are expressed in late G1 and early S phase of the cell 
cycle. Nrm1 is involved in the regulation of the cellular response to replication stress via the 
Rad53 dependent pathway (Travesa et al., 2012). Preliminary observations have found that Set1 
complex methylates Nrm1 in vitro (B. Dichtl, unpublished data). Those findings led to the quest 
for whether the Set1 complex could interact with Nrm1 in vivo and whether this interaction could 
impact on Nrm1 stability and function. My study aimed to establish a functional connection 
between chromatin structure modulation and the regulation of the cell cycle.  
First of all, to find out whether Set1 is required to determine the normal Nrm1 levels in the cells, 
I have transformed two yeast strains (Δnrm1 and Δnrm1Δset1) with three plasmids (wt, ΔN-
Nrm1, and Nrm1-AAA)  and generated six mutants as mentioned in section 3.1. Mutants obtained 
from Δnrm1 strain contained the SET1  gene and were able to produce Set1 protein whereas 
mutants obtained from Δnrm1Δset1 strain didn’t contain the SET1 gene and therefore were 
unable to produce Set1 protein. Besides wt plasmids, I have used ΔN-Nrm1 plasmid to check if 
the destruction box impacts on Nrm1 protein abundance. The previous study by using the yeast 
two-hybrid system has revealed that Swd1 (which is one of the subunits of Set1 complex) 
identifies an H3K4-like sequence present in Nrm1(see Fig 1.5) and from that study, it was 
assumed that Set1C might act on 118 lysine residue (K118) on Nrm1 (B. Dichtl, unpublished data). 
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So, I have used Nrm1-AAA plasmid (that had K116TK118QT sequence of Nrm1 mutated to 
A116AA118QT) to check if K118 residue is essential for Set1C binding.   
For the analysis of Nrm1 protein abundance, I had harvested the cells at OD600  of ~0.5, which is 
the log phase, when the number of cells increases exponentially. A population of cells growing in 
log phase is considered to be at the steady-state. I used the immunoblot techniques to determine 
whether Set1 impacts the steady state Nrm1 protein levels.  From my results, cells that don’t 
have SET1 gene were found to have a lower level of Nrm1 protein than those cells that have SET1 
(see fig 3.1.2). wt-nrm1 Δset1 mutant has less than half Nrm1 protein level than that of its wild 
type. This suggests that Set1 protein is required to maintain the proper levels of Nrm1 in the cell. 
There could be two possibilities for this; one, Set1 directly methylates Nrm1, or other, Set1 
regulates the NRM1 gene transcription. Set1 has been known to influence the transcription of 
various genes (Ardehali et al., 2011, Ramakrishnan et al., 2016). So, there is a chance that Set1 
can influence the transcription of NRM1 gene. However, I have only determined the steady-state 
Nrm1 protein levels. So, further research should be done to find out the potential role of Set1 in 
NRM1 gene transcription. 
As compared to WT cells, ΔN mutants show a higher level of Nrm1 protein expression (see fig 
3.1.2). ΔN mutants have their destruction box or D-box deleted. The destruction box is a short 
peptide motif (9 to 13 amino acids) present at the N terminus of Nrm1 protein as well as other 
cyclin proteins (Meyn Iii et al., 2002). D-box is crucial for cyclin ubiquitination following 
proteolysis. ΔN mutants that lack the D-box motif fail to recognize the substrate involved in 
proteolysis, thus have higher protein stability (Ostapenko and Solomon, 2011). ΔN-nrm1 cells 
have the highest protein abundance among all mutants. In this case, the Set1 mediates the 
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normal Nrm1 protein levels, but due to the deletion of D-box, Nrm1 protein stability increases 
which further contributes to protein abundance. Also, ΔN-nrm1 Δset1 mutants have a 
significantly high Nrm1 level almost nearly equal to wild-type. This can be also attributed to the 
increase in protein stability. 
It was presumed that Set1 binds Nrm1 at Lysine-118 (K118) position. In -AAA mutants, the Set1 
interaction domain of Nrm1, K116TK118QT, is mutated to A116AA118QT. Surprisingly, my data show 
that nrm1-AAA mutants also have significantly high Nrm1 protein levels, nearly equal to the WT 
cells (see fig 3.1.2). This result suggests that K118 residue does not play an essential role in the 
expression of Nrm1 protein levels or probably isn’t required for the Set1 binding. Previous data 
(B. Dichtl, unpublished data) have indicated that Nrm1-AAA protein, which contains altered 
K118A residue, can be methylated in vitro suggesting that there is a prospect of methylation sites 
other than K118A residue.  
To characterize the interaction between Set1 and Nrm1, which addresses the second aim of my 
project, I have determined the Nrm1 protein stability in the presence and absence of the SET1 
gene. The half-lives in wt-nrm1 Δset1 and nrm1-AAA Δset1 mutants were found to be decreased 
by almost half than that of wt-nrm1 and nrm1-AAA respectively (see Table 3.1). That’s the 
significant difference found between the cells that have the SET1 gene and the ones which do 
not have the SET1 gene. The results implicate that Nrm1 protein stability is strongly influenced 
by Set1 histone methyltransferase or its activity. But how does Set1 impact on Nrm1 stability?  
Cell cycle progression is regulated by the sequential degradation of various cell cycle proteins. 
Cell cycle protein degradation is mediated mainly through ubiquitin-proteasome pathways 
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(Reed, 2006). A ubiquitin chain is covalently bound to the target protein which is then 
subsequently recognized and degraded by a large cytosolic protease complex called 26S 
proteasome. Ubiquitination involves three main steps involving the function of E1, E2, and E3 
enzymes. E3 enzymes, ubiquitin ligases, are important in this pathway since they confer the 
substrate specificity (Nakayama and Nakayama, 2005). Anaphase promoting complex /cyclosome 
(APC/C) is one of the ubiquitin ligases. A study by Ostapenko and Solomon (2011) suggests that 
degradation of Nrm1 proteins relies on Anaphase promoting complex (APC). APC is a large 
protein complex consisting of 13 subunits which include WD40 repeat-containing activator, 
either Cdc20 or Cdh1. Ostapenko and Solomon (2011) also found that Nrm1 can be stabilized by 
phosphorylation possibly by Cdc28, a cyclic-dependent kinase (Cdk). Therefore, Nrm1 
stabilization is controlled by APC-Cdh1  mediated degradation and phosphorylation by Cdc28. 
In another study by Zhang et al. (2005), the interaction between Set1 methyltransferase and Ipl1 
aurora kinase was established. The kinetochore protein Dam1 is a subunit of ten-member Dam1 
complex which helps to form rings around microtubules by oligomerization and those rings aid 
to attach the kinetochore to the microtubules. Dam1 is an important substrate for Ipl1 and 
phosphorylation of Dam1 by Ipl1 is important for proper microtubule-kinetochore attachment 
and chromosome segregation (Latham et al., 2011). Dam1 is methylated by Set1 at K233. K233 
has flanking serines at S232, S234, and S235. So, Zhang et al. (2005) suggested that methylation 
at K233 by Set1 negatively regulates the phosphorylation of surrounding serines by Ipl1 (see fig 
1.6).  
The data which I have obtained suggest that in the cells which have SET1 were found to have 
more stabilized Nrm1 protein. If methylation by Set1 was meant to oppose the phosphorylation 
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by Cdc28, the Nrm1 stability would decrease. But my result suggests that methylation by Set1 
rather increases Nrm1 stability, indicating that methylation by Set1 has no impact on 
phosphorylation by Cdc28. Nrm1 does encompass many Ser-Pro/Thr-Pro consensus Cdc28 
phosphorylation sites (Ostapenko and Solomon, 2011, Ubersax et al., 2003), but these sites, in a 
folded protein, might be located far from the Set1 methylation site. However, there is the 
possibility that methylation by Set1 could oppose ubiquitination by APC and thus repressing the 
APC-Cdh1  mediated degradation of Nrm1. Previous studies have found that ubiquitin ligase activity 
can be blocked by lysine methylation (Michalek et al., 1996, Pang et al., 2010). In a study by 
Chuikov et al. (2004) found that p53 tumor suppressor protein in human can be methylated by 
Set9 methyltransferase. Set9 methyltransferase is a member of the SET domain-containing family 
which catalyzes H3K4 methylation in humans. Additionally, methylation of p53 at k372 residue 
by Set9 increased p53 protein stability. This can be related to my findings. The data which I have 
obtained also show that in SET1 containing wild-type cells, Nrm1 protein stability was higher. This 
is probably due to Nrm1 methylation by Set1 which opposes the ubiquitin ligase (APC) function 
thus repressing the APC-Cdh1  mediated degradation of Nrm1. In nrm1-AAA mutants, Nrm1 
stability was found to be similar to WT which further supports my previously mentioned finding 
that K118 residue in Nrm1 is not essential for Set1 interaction. 
To address the third aim of my project, I further characterized the interaction between Set1 and 
Nrm1 in the presence and absence of replication stress by using the co-immunoprecipitation 
technique. The co-immunoprecipitation results also showed that there is an interaction between 
Nrm1 and Set1. Hydroxyurea (HU) induces the replication stress in the yeast cells. In HU treated 
ProtA-nrm1 + HA3-set1  cells, the protein binding of the co-immunoprecipitated proteins was 
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higher than HU untreated cells which imply that the interaction between Nrm1 and Set1 changes 
in the presence of replication stress (see fig 3.3.1). A study by Travesa et al. (2012) had found 
that Nrm1 can be directly phosphorylated by the checkpoint effector protein kinase Rad53 in the 
response to replication stress. When phosphorylated, Nrm1 cannot bind to MBF and thus 
resulting in induction of MBF-regulated transcriptions, many of which encode DNA replication 
and repair proteins. My data suggest that the interaction between Nrm1 and Set1 increases in 
the presence of replication stress indicating that Nrm1 methylation by Set1 is induced to cope up 
with replication stress. In this case, the methylation by Set1 may aid the phosphorylation by 
Rad53. There is also another possibility that Rad-53 dependent inactivation of Nrm1 during 
replication stress leads Nrm1 release from MBF which increases the availability of Nrm1 for 
methylation by Set1. Having said that, there is the necessity of performing the Co-IP experiment 
again to be more confident about the result. 
From the results that I’ve observed and the results from other studies, I have proposed a model 
for Nrm1 methylation in Figure 4.1 below. Methylation by Set1 may affect other post-
translational modifications of Nrm1. I propose that methylation on Nrm1 opposes the 
ubiquitination by APC and thus represses the APC mediated degradation of Nrm1 that 
contributes to the increase in Nrm1 stability. I also propose that the Nrm1 methylation rate 
increases during replication stress and the methylation may positively regulate the Rad53 
dependent phosphorylation on Nrm1  to cope up with the replication stress. 
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Fig 4.1: Model for Nrm1 methylation by Set1 and its role in modulating the activity of other enzymes. (A) My data 
suggests that Set1 interacts with Nrm1. This interaction possibly through the methylation on Nrm1 by Set1. (B) I 
propose that the methylation by Set1 opposes ubiquitin ligase (APC) function thus repressing the APC-Cdh1  mediated 
degradation of Nrm1 which contributes to higher Nrm1 protein stability. (C) When the cells encounter replication 
stress, the methylation rate on Nrm1 by Set1 increases, and this methylation may positively regulate Rad53 
dependent phosphorylation of Nrm1 that leads to the dissociation of Nrm1 from MBF. 
 
A study by (Beilharz et al., 2017) has found that H3K4 methylation by Set1C is required for 
microtubule stability and is required to prepare the cells for proper mitosis further down the cell 
cycle.  Beilharz et al. (2017) have found that in Δset1 cells, expressions of genes involved in G1/S 
transition of the cell cycle were misregulated. Beilharz et al. (2017) have suggested the possibility 
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of chromatin modification to regulate the cell cycle events, but the exact mechanism is yet to be 
uncovered.  The interaction between the Set1 and Nrm1  revealed from my study can be one of 
the mechanisms by which Set1 methyltransferase controls the regulation of G1/S transition and 
the cell cycle progression. 
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CHAPTER V: CONCLUSION AND FUTURE 
DIRECTIONS 
 
Protein-protein interactions play an important role in cellular functions and biological processes 
in all organisms. In my study, Set1 histone methyltransferase which catalyzes Histone-3-Lysine-4 
methylation in Saccharomyces cerevisiae was found to interact with a non-histone substrate, 
Nrm1 in vivo. Nrm1 is a co-repressor of MBF, which regulates the cellular response to replication 
stress, acts during the G1/S phase of the cell cycle. The interaction between Set1 and Nrm1 can 
be via Set1 directly methylating Nrm1 at lysine residue. Further research should be done to find 
out the exact methylation site on Nrm1 because methylation can influence other post-
translational modifications on Nrm1 close to the methylation site. Additionally, there is also the 
possibility that Set1 may impact the transcription of NRM1 gene. This should be also addressed 
by future research. My study has also found that Nrm1 stability and function are influenced by 
Set1. The yeast Set1 Complex is the prime model to understand the function of related complexes 
in human cells including the MLL complexes, which are involved in several devastating 
hematological malignancies. My research has added another layer of functional understanding 
about histone methyltransferase and their involvement in the regulation of replication stress. 
Therefore, my research can be a blueprint for future researches on human diseases like leukemia 
derived from MLL abnormalities.  
P a g e  | 55 
 
REFERENCES: 
 
Thermo Fisher Scientific, 2020, Epigenetics, retrieved 15 April 2020, 
<https://www.thermofisher.com/au/en/home/life-science/antibodies/antibodies-learning-
center/antibodies-resource-library/antibody-methods/epigenetics.html>  
AJIRO, K. 2000. Histone H2B phosphorylation in mammalian apoptotic cells An association with DNA 
fragmentation. Journal of Biological Chemistry, 275, 439-443. 
ANSARI, K. I., MISHRA, B. P. & MANDAL, S. S. 2009. MLL histone methylases in gene expression, 
hormone signaling and cell cycle. Front Biosci, 14, 3483-3495. 
ARDEHALI, M. B., MEI, A., ZOBECK, K. L., CARON, M., LIS, J. T. & KUSCH, T. 2011. Drosophila Set1 is the 
major histone H3 lysine 4 trimethyltransferase with role in transcription. The EMBO journal, 30, 
2817-2828. 
BÄHLER, J. 2005. Cell-cycle control of gene expression in budding and fission yeast. Annu. Rev. Genet., 
39, 69-94. 
BANNISTER, A. J. & KOUZARIDES, T. 2003. Histone methylation: recognizing the methyl mark. Methods in 
enzymology. Elsevier. 
BANNISTER, A. J. & KOUZARIDES, T. 2011. Regulation of chromatin by histone modifications. Cell 
research, 21, 381-395. 
BEDNAR, J., GARCIA-SAEZ, I., BOOPATHI, R., CUTTER, A. R., PAPAI, G., REYMER, A., SYED, S. H., LONE, I. 
N., TONCHEV, O., CRUCIFIX, C., MENONI, H., PAPIN, C., SKOUFIAS, D. A., KURUMIZAKA, H., 
LAVERY, R., HAMICHE, A., HAYES, J. J., SCHULTZ, P., ANGELOV, D., PETOSA, C. & DIMITROV, S. 
2017. Structure and Dynamics of a 197 bp Nucleosome in Complex with Linker Histone H1. 
Molecular Cell, 66, 384-397.e8. 
BEDNAR, J., HOROWITZ, R. A., GRIGORYEV, S. A., CARRUTHERS, L. M., HANSEN, J. C., KOSTER, A. J. & 
WOODCOCK, C. L. 1998. Nucleosomes, linker DNA, and linker histone form a unique structural 
motif that directs the higher-order folding and compaction of chromatin. Proceedings of the 
National Academy of Sciences, 95, 14173-14178. 
BEILHARZ, T. H., HARRISON, P. F., MILES, D. M., SEE, M. M., LE, U. M. M., KALANON, M., CURTIS, M. J., 
HASAN, Q., SAKSOUK, J. & MARGARITIS, T. 2017. Coordination of cell cycle progression and 
mitotic spindle assembly involves histone H3 lysine 4 methylation by Set1/COMPASS. Genetics, 
205, 185-199. 
BEN-HAÏM, E., LESNE, A. & VICTOR, J.-M. 2001. Chromatin: a tunable spring at work inside 
chromosomes. Physical Review E, 64, 051921. 
BENSON, L. J., GU, Y., YAKOVLEVA, T., TONG, K., BARROWS, C., STRACK, C. L., COOK, R. G., MIZZEN, C. A. 
& ANNUNZIATO, A. T. 2006. Modifications of H3 and H4 during chromatin replication, 
nucleosome assembly, and histone exchange. Journal of Biological Chemistry, 281, 9287-9296. 
BERGGÅRD, T., LINSE, S. & JAMES, P. 2007. Methods for the detection and analysis of protein–protein 
interactions. Proteomics, 7, 2833-2842. 
BERTOLI, C., SKOTHEIM, J. M. & DE BRUIN, R. A. 2013. Control of cell cycle transcription during G1 and S 
phases. Nature reviews Molecular cell biology, 14, 518. 
P a g e  | 56 
 
BLACK, JOSHUA C., VAN RECHEM, C. & WHETSTINE, JOHNATHAN R. 2012. Histone Lysine Methylation 
Dynamics: Establishment, Regulation, and Biological Impact. Molecular Cell, 48, 491-507. 
BRADFORD, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of 
protein utilizing the principle of protein-dye binding. Analytical biochemistry, 72, 248-254. 
CAMPOS, E. I. & REINBERG, D. 2009. Histones: Annotating Chromatin. Annual Review of Genetics, 43, 
559-599. 
CHEESEMAN, I. M., ANDERSON, S., JWA, M., GREEN, E. M., KANG, J.-S., YATES, J. R., CHAN, C. S. M., 
DRUBIN, D. G. & BARNES, G. 2002. Phospho-Regulation of Kinetochore-Microtubule 
Attachments by the Aurora Kinase Ipl1p. Cell, 111, 163-172. 
CHUIKOV, S., KURASH, J. K., WILSON, J. R., XIAO, B., JUSTIN, N., IVANOV, G. S., MCKINNEY, K., TEMPST, 
P., PRIVES, C. & GAMBLIN, S. J. 2004. Regulation of p53 activity through lysine methylation. 
Nature, 432, 353-360. 
CLEMENTS, A., POUX, A. N., LO, W.-S., PILLUS, L., BERGER, S. L. & MARMORSTEIN, R. 2003. Structural 
basis for histone and phosphohistone binding by the GCN5 histone acetyltransferase. Molecular 
cell, 12, 461-473. 
CUTHBERT, G. L., DAUJAT, S., SNOWDEN, A. W., ERDJUMENT-BROMAGE, H., HAGIWARA, T., YAMADA, 
M., SCHNEIDER, R., GREGORY, P. D., TEMPST, P. & BANNISTER, A. J. 2004. Histone deimination 
antagonizes arginine methylation. Cell, 118, 545-553. 
DAI, J., SULTAN, S., TAYLOR, S. S. & HIGGINS, J. M. 2005. The kinase haspin is required for mitotic histone 
H3 Thr 3 phosphorylation and normal metaphase chromosome alignment. Genes & 
development, 19, 472-488. 
DE BRUIN, R., KALASHNIKOVA, T., ASLANIAN, A., WOHLSCHLEGEL, J., CHAHWAN, C., YATES, J., RUSSELL, 
P. & WITTENBERG, C. 2008. DNA replication checkpoint promotes G1-S transcription by 
inactivating the MBF repressor Nrm1. Proceedings of the National Academy of Sciences, 105, 
11230-11235. 
DE BRUIN, R. A. & WITTENBERG, C. 2009. All eukaryotes: before turning off G1-S transcription, please 
check your DNA. Cell Cycle, 8, 214-217. 
DE KONING, L., CORPET, A., HABER, J. E. & ALMOUZNI, G. 2007. Histone chaperones: an escort network 
regulating histone traffic. Nature structural & molecular biology, 14, 997-1007. 
DEHÉ, P.-M., DICHTL, B., SCHAFT, D., ROGUEV, A., PAMBLANCO, M., LEBRUN, R., RODRÍGUEZ-GIL, A., 
MKANDAWIRE, M., LANDSBERG, K. & SHEVCHENKO, A. 2006. Protein interactions within the 
Set1 complex and their roles in the regulation of histone 3 lysine 4 methylation. Journal of 
biological chemistry, 281, 35404-35412. 
DEHE, P.-M. & GELI, V. 2006. The multiple faces of Set1. Biochemistry and cell biology, 84, 536-548. 
DICKEY, J. S., REDON, C. E., NAKAMURA, A. J., BAIRD, B. J., SEDELNIKOVA, O. A. & BONNER, W. M. 2009. 
H2AX: functional roles and potential applications. Chromosoma, 118, 683-692. 
DILLON, S. C., ZHANG, X., TRIEVEL, R. C. & CHENG, X. 2005. The SET-domain protein superfamily: protein 
lysine methyltransferases. Genome Biology, 6, 227. 
DIXON, J. R., GORKIN, D. U. & REN, B. 2016. Chromatin domains: the unit of chromosome organization. 
Molecular cell, 62, 668-680. 
DOWNS, J. A., ALLARD, S., JOBIN-ROBITAILLE, O., JAVAHERI, A., AUGER, A., BOUCHARD, N., KRON, S. J., 
JACKSON, S. P. & CÔTÉ, J. 2004. Binding of chromatin-modifying activities to phosphorylated 
histone H2A at DNA damage sites. Molecular cell, 16, 979-990. 
GARCIA, B. A., SHABANOWITZ, J. & HUNT, D. F. 2007. Characterization of histones and their post-
translational modifications by mass spectrometry. Current opinion in chemical biology, 11, 66-
73. 
GERACE, E. & MOAZED, D. 2014. Coimmunoprecipitation of proteins from yeast. Methods in 
enzymology. Elsevier. 
P a g e  | 57 
 
GIETZ, R. D. & SCHIESTL, R. H. 2007. High-efficiency yeast transformation using the LiAc/SS carrier 
DNA/PEG method. Nature protocols, 2, 31-34. 
GREER, E. L. & SHI, Y. 2012. Histone methylation: a dynamic mark in health, disease and inheritance. 
Nature Reviews Genetics, 13, 343-357. 
HWANG, W. W., VENKATASUBRAHMANYAM, S., IANCULESCU, A. G., TONG, A., BOONE, C. & MADHANI, 
H. D. 2003. A conserved RING finger protein required for histone H2B monoubiquitination and 
cell size control. Molecular cell, 11, 261-266. 
JOSSEN, R. & BERMEJO, R. 2013. The DNA damage checkpoint response to replication stress: A Game of 
Forks. Frontiers in genetics, 4, 26. 
KARLIĆ, R., CHUNG, H.-R., LASSERRE, J., VLAHOVIČEK, K. & VINGRON, M. 2010. Histone modification 
levels are predictive for gene expression. Proceedings of the National Academy of Sciences, 107, 
2926-2931. 
KLOSE, R. J. & ZHANG, Y. 2007. Regulation of histone methylation by demethylimination and 
demethylation. Nature reviews Molecular cell biology, 8, 307-318. 
KOUZARIDES, T. 2002. Histone methylation in transcriptional control. Current Opinion in Genetics & 
Development, 12, 198-209. 
KROGAN, N. J., DOVER, J., KHORRAMI, S., GREENBLATT, J. F., SCHNEIDER, J., JOHNSTON, M. & 
SHILATIFARD, A. 2002. COMPASS, a histone H3 (Lysine 4) methyltransferase required for 
telomeric silencing of gene expression. Journal of biological chemistry, 277, 10753-10755. 
KURDISTANI, S. K. & GRUNSTEIN, M. 2003. Histone acetylation and deacetylation in yeast. Nature 
reviews Molecular cell biology, 4, 276-284. 
LATHAM, J. A., CHOSED, R. J., WANG, S. & DENT, S. Y. 2011. Chromatin signaling to kinetochores: 
transregulation of Dam1 methylation by histone H2B ubiquitination. Cell, 146, 709-719. 
LEONARD, A. C. & MÉCHALI, M. 2013. DNA replication origins. Cold Spring Harbor perspectives in 
biology, 5, a010116. 
LUGER, K., MÄDER, A. W., RICHMOND, R. K., SARGENT, D. F. & RICHMOND, T. J. 1997. Crystal structure 
of the nucleosome core particle at 2.8 Å resolution. Nature, 389, 251-260. 
MA, M. K.-W., HEATH, C., HAIR, A. & WEST, A. G. 2011. Histone crosstalk directed by H2B ubiquitination 
is required for chromatin boundary integrity. PLoS genetics, 7. 
MAGDALOU, I., LOPEZ, B. S., PASERO, P. & LAMBERT, S. A. The causes of replication stress and their 
consequences on genome stability and cell fate.  Seminars in cell & developmental biology, 
2014. Elsevier, 154-164. 
MALIK, S. & BHAUMIK, S. R. 2010. Mixed lineage leukemia: histone H3 lysine 4 methyltransferases from 
yeast to human. The FEBS journal, 277, 1805-1821. 
MARESCA, T. J., FREEDMAN, B. S. & HEALD, R. 2005. Histone H1 is essential for mitotic chromosome 
architecture and segregation in Xenopus laevis egg extracts. The Journal of cell biology, 169, 
859-869. 
MASSAGUÉ, J. 2004. G1 cell-cycle control and cancer. Nature, 432, 298-306. 
MAZOUZI, A., VELIMEZI, G. & LOIZOU, J. I. 2014. DNA replication stress: causes, resolution and disease. 
Experimental cell research, 329, 85-93. 
MCINERNY, C. J. 2016. Cell cycle regulated transcription: from yeast to cancer. F1000Research, 5, F1000 
Faculty Rev-877. 
MCMAHON, D. 1975. Cycloheximide is not a specific inhibitor of protein synthesis in vivo. Plant 
Physiology, 55, 815-821. 
MEYN III, M. A., MELLOY, P. G., LI, J. & HOLLOWAY, S. L. 2002. The destruction box of the cyclin Clb2 
binds the anaphase-promoting complex/cyclosome subunit Cdc23. Archives of biochemistry and 
biophysics, 407, 189-195. 
P a g e  | 58 
 
MICHALEK, M. T., GRANT, E. P. & ROCK, K. L. 1996. Chemical denaturation and modification of 
ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation. The 
Journal of Immunology, 157, 617-624. 
NAKAYAMA, K. I. & NAKAYAMA, K. Regulation of the cell cycle by SCF-type ubiquitin ligases.  Seminars in 
cell & developmental biology, 2005. Elsevier, 323-333. 
NATHAN, D., STERNER, D. E. & BERGER, S. L. 2003. Histone modifications: Now summoning sumoylation. 
Proceedings of the National Academy of Sciences, 100, 13118-13120. 
NELSON, D. L., LEHNINGER, A. L. & COX, M. M. 2008. Lehninger principles of biochemistry, Macmillan. 
NG, H. H., ROBERT, F., YOUNG, R. A. & STRUHL, K. 2003. Targeted recruitment of Set1 histone methylase 
by elongating Pol II provides a localized mark and memory of recent transcriptional activity. 
Molecular cell, 11, 709-719. 
NIIDA, H., SHIMADA, M., MURAKAMI, H. & NAKANISHI, M. 2010. Mechanisms of dNTP supply that play 
an essential role in maintaining genome integrity in eukaryotic cells. Cancer science, 101, 2505-
2509. 
NISHIOKA, K., CHUIKOV, S., SARMA, K., ERDJUMENT-BROMAGE, H., ALLIS, C. D., TEMPST, P. & REINBERG, 
D. 2002. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding 
histone tail modifications required for heterochromatin formation. Genes & development, 16, 
479-489. 
OFIR, A., HOFMANN, K., WEINDLING, E., GILDOR, T., BARKER, K. S., ROGERS, P. D. & KORNITZER, D. 2012. 
Role of a Candida albicans Nrm1/Whi5 homologue in cell cycle gene expression and DNA 
replication stress response. Molecular microbiology, 84, 778-794. 
OSTAPENKO, D. & SOLOMON, M. J. 2011. Anaphase promoting complex–dependent degradation of 
transcriptional repressors Nrm1 and Yhp1 in Saccharomyces cerevisiae. Molecular biology of the 
cell, 22, 2175-2184. 
PANG, C. N. I., GASTEIGER, E. & WILKINS, M. R. 2010. Identification of arginine-and lysine-methylation in 
the proteome of Saccharomyces cerevisiae and its functional implications. BMC genomics, 11, 
92. 
PARK, I.-K., QIAN, D., KIEL, M., BECKER, M. W., PIHALJA, M., WEISSMAN, I. L., MORRISON, S. J. & CLARKE, 
M. F. 2003. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. 
Nature, 423, 302-305. 
PESTOVA, T. V. & HELLEN, C. U. 2003. Translation elongation after assembly of ribosomes on the Cricket 
paralysis virus internal ribosomal entry site without initiation factors or initiator tRNA. Genes & 
development, 17, 181-186. 
PETERSON, C. L. & LANIEL, M.-A. 2004. Histones and histone modifications. Current Biology, 14, R546-
R551. 
POIRIER, M. G. & MARKO, J. F. 2002. Mitotic chromosomes are chromatin networks without a 
mechanically contiguous protein scaffold. Proceedings of the National Academy of Sciences, 99, 
15393-15397. 
RAMAKRISHNAN, S., POKHREL, S., PALANI, S., PFLUEGER, C., PARNELL, T. J., CAIRNS, B. R., BHASKARA, S. 
& CHANDRASEKHARAN, M. B. 2016. Counteracting H3K4 methylation modulators Set1 and Jhd2 
co-regulate chromatin dynamics and gene transcription. Nature communications, 7, 1-16. 
REED, S. I. 2006. The ubiquitin-proteasome pathway in cell cycle control. Cell Cycle Regulation. Springer. 
ROBINSON, P. J. & RHODES, D. 2006. Structure of the ‘30 nm’chromatin fibre: a key role for the linker 
histone. Current opinion in structural biology, 16, 336-343. 
ROGUEV, A., SCHAFT, D., SHEVCHENKO, A., PIJNAPPEL, W. W. M. P., WILM, M., AASLAND, R. & 
STEWART, A. F. 2001. The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue 
and methylates histone 3 lysine 4. The EMBO Journal, 20, 7137-7148. 
P a g e  | 59 
 
ROSSETTO, D., AVVAKUMOV, N. & CÔTÉ, J. 2012. Histone phosphorylation: a chromatin modification 
involved in diverse nuclear events. Epigenetics, 7, 1098-1108. 
SASSONE-CORSI, P., MIZZEN, C. A., CHEUNG, P., CROSIO, C., MONACO, L., JACQUOT, S., HANAUER, A. & 
ALLIS, C. D. 1999. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation 
of histone H3. Science, 285, 886-891. 
SCHNEIDER, J., WOOD, A., LEE, J.-S., SCHUSTER, R., DUEKER, J., MAGUIRE, C., SWANSON, S. K., FLORENS, 
L., WASHBURN, M. P. & SHILATIFARD, A. 2005. Molecular regulation of histone H3 
trimethylation by COMPASS and the regulation of gene expression. Molecular cell, 19, 849-856. 
SHAHBAZIAN, M. D. & GRUNSTEIN, M. 2007. Functions of site-specific histone acetylation and 
deacetylation. Annu. Rev. Biochem., 76, 75-100. 
SHI, Y., LAN, F., MATSON, C., MULLIGAN, P., WHETSTINE, J. R., COLE, P. A., CASERO, R. A. & SHI, Y. 2004. 
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell, 119, 941-
953. 
SHI, Y. & WHETSTINE, J. R. 2007. Dynamic Regulation of Histone Lysine Methylation by Demethylases. 
Molecular Cell, 25, 1-14. 
SHILATIFARD, A. 2008. Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) 
methylation. Current opinion in cell biology, 20, 341-348. 
SHILATIFARD, A. 2012. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in 
development and disease pathogenesis. Annual review of biochemistry, 81, 65-95. 
SMOLKA, M. B., BASTOS DE OLIVEIRA, F. M., HARRIS, M. R. & DE BRUIN, R. A. 2012. The checkpoint 
transcriptional response: make sure to turn it off once you are satisfied. Cell Cycle, 11, 3166-
3174. 
SOARES, L. M., RADMAN-LIVAJA, M., LIN, S. G., RANDO, O. J. & BURATOWSKI, S. 2014. Feedback control 
of Set1 protein levels is important for proper H3K4 methylation patterns. Cell reports, 6, 961-
972. 
SOLLIER, J., LIN, W., SOUSTELLE, C., SUHRE, K., NICOLAS, A., GÉLI, V. & SAINT‐ANDRÉ, C. D. L. R. 2004. 
Set1 is required for meiotic S‐phase onset, double‐strand break formation and middle gene 
expression. The EMBO journal, 23, 1957-1967. 
SZE, C. C. & SHILATIFARD, A. 2016. MLL3/MLL4/COMPASS family on epigenetic regulation of enhancer 
function and cancer. Cold Spring Harbor perspectives in medicine, 6, a026427. 
TAKAHASHI, Y.-H., WESTFIELD, G. H., OLESKIE, A. N., TRIEVEL, R. C., SHILATIFARD, A. & SKINIOTIS, G. 
2011. Structural analysis of the core COMPASS family of histone H3K4 methylases from yeast to 
human. Proceedings of the National Academy of Sciences, 108, 20526-20531. 
TAMBURINI, B. A. & TYLER, J. K. 2005. Localized histone acetylation and deacetylation triggered by the 
homologous recombination pathway of double-strand DNA repair. Molecular and cellular 
biology, 25, 4903-4913. 
TAN, S. & DAVEY, C. A. 2011. Nucleosome structural studies. Current opinion in structural biology, 21, 
128-136. 
TRAVESA, A., KUO, D., DE BRUIN, R. A., KALASHNIKOVA, T. I., GUADERRAMA, M., THAI, K., ASLANIAN, A., 
SMOLKA, M. B., YATES, J. R. & IDEKER, T. 2012. DNA replication stress differentially regulates 
G1/S genes via Rad53‐dependent inactivation of Nrm1. The EMBO journal, 31, 1811-1822. 
TURNER, B. M. & O'NEILL, L. P. Histone acetylation in chromatin and chromosomes.  Seminars in cell 
biology, 1995. Elsevier, 229-236. 
UBERSAX, J. A., WOODBURY, E. L., QUANG, P. N., PARAZ, M., BLETHROW, J. D., SHAH, K., SHOKAT, K. M. 
& MORGAN, D. O. 2003. Targets of the cyclin-dependent kinase Cdk1. Nature, 425, 859-864. 
VAN NULAND, R., SMITS, A. H., PALLAKI, P., JANSEN, P. W., VERMEULEN, M. & TIMMERS, H. M. 2013. 
Quantitative dissection and stoichiometry determination of the human SET1/MLL histone 
methyltransferase complexes. Molecular and cellular biology, 33, 2067-2077. 
P a g e  | 60 
 
WANG, H., ZHAI, L., XU, J., JOO, H.-Y., JACKSON, S., ERDJUMENT-BROMAGE, H., TEMPST, P., XIONG, Y. & 
ZHANG, Y. 2006. Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase 
facilitates cellular response to DNA damage. Molecular cell, 22, 383-394. 
WEAKE, V. M. & WORKMAN, J. L. 2008. Histone ubiquitination: triggering gene activity. Molecular cell, 
29, 653-663. 
XIAO, T., KAO, C.-F., KROGAN, N. J., SUN, Z.-W., GREENBLATT, J. F., OSLEY, M. A. & STRAHL, B. D. 2005. 
Histone H2B ubiquitylation is associated with elongating RNA polymerase II. Molecular and 
cellular biology, 25, 637-651. 
XIE, M., YEN, Y., OWONIKOKO, T. K., RAMALINGAM, S. S., KHURI, F. R., CURRAN, W. J., DOETSCH, P. W. & 
DENG, X. 2014. Bcl2 induces DNA replication stress by inhibiting ribonucleotide reductase. 
Cancer research, 74, 212-223. 
ZEMAN, M. K. & CIMPRICH, K. A. 2014. Causes and consequences of replication stress. Nature cell 
biology, 16, 2-9. 
ZHANG, K., LIN, W., LATHAM, J. A., RIEFLER, G. M., SCHUMACHER, J. M., CHAN, C., TATCHELL, K., HAWKE, 
D. H., KOBAYASHI, R. & DENT, S. Y. 2005. The Set1 methyltransferase opposes Ipl1 aurora kinase 
functions in chromosome segregation. Cell, 122, 723-734. 
ZHANG, L., GURSKAYA, N. G., MERZLYAK, E. M., STAROVEROV, D. B., MUDRIK, N. N., SAMARKINA, O. N., 
VINOKUROV, L. M., LUKYANOV, S. & LUKYANOV, K. A. 2007. Method for real-time monitoring of 
protein degradation at the single cell level. Biotechniques, 42, 446-450. 
 
 
 
 
 
 
